TechSurge: Deep Tech Podcast · 2025-03-13 · 42 min
Many in venture capital and biopharma are anointing artificial intelligence the savior of drug discovery - but what can AI actually do? In this eye-opening episode, Michael Marks sits down with Mike Nohaile, CEO of Prellis Biologics, to explore the hype versus reality in AI-enabled drug discovery. Mike details why, despite significant breakthroughs like AlphaFold and recent Nobel Prize win for computational protein design, fully AI-generated medicines still present challenges. He also discusses why we urgently need more effective medicines and details Prellis’ unique system which combines laser printed human organoids and an externalized human immune system with AI, enabling the discovery of fully human antibodies. If you enjoy this episode, please subscribe and leave us a review on your favorite podcast platform.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Less about Models; More about ArchitecturePractical AI · on Artificial intelligence85 / 100
321 | How to Build an AI App Without Coding: From Idea to App Store with Replit & Claude by Bryce Rattner KeithleyLeveraging AI · on Artificial intelligence80 / 100
Rapid Response: OpenAI’s Critterz blowback - Director Nik Kleverov on year zero for HollywoodPioneers of AI · on Artificial intelligence76 / 100
He Made It To The NFL. Now He Wants To Prove Himself All Over Again.Catalyst by Camber Creek · on Venture capital74 / 100
Edward Robson - Capital Allocation in TechnologyCloud Returns · on Venture capital68 / 100
#191 - Battling AI Fear: Storytelling, Technology, and Disruptive Change with Paul Roehrig, Chief Strategy and Marketing Officer at AscendionFinite By Clarity · on Artificial intelligence60 / 100
The Race to Build the Next Trillion-Dollar AI Chip Company90 / 100
The Moving Bottleneck: Networking, Power, Memory, and the Race to Win AI87 / 100
Battle for the AI Data Center: Deep Dive on the Semiconductor Supercycle84 / 100
In-Orbit Manufacturing, AI Data Centers, and the New Space Economy with MIT’s Ariel Ekblaw77 / 100
The U.S. - China Deep Tech Arms Race79 / 100